-
30 April 2025 07:01:28
- Source: Sharecast

30 April 2025
BUNZL ANNOUNCES ACQUISITIONS IN CHILE AND THE NETHERLANDS
Bunzl plc, the specialist international distribution and services Group, today announces that it has signed an agreement to acquire a business in Chile and has completed the acquisition of a business in the Netherlands.
Bunzl has entered into an agreement to acquire Hospitalia, one of the largest healthcare distributors in Chile. The business distributes a wide range of products, including those used in a surgical setting, to both public and private hospitals. This represents our entry into the healthcare sector in Chile, with the business generating revenue of CLP 25 billion (c.£21 million) in 2024. Completion of the acquisition is subject to competition authority clearance, which is expected in the next few months.
Bunzl has also completed the acquisition of Inpakomed, a Dutch business specialising in sterile product packaging solutions for use in the medical and forensic markets. The business is highly complementary to our existing business in the Netherlands and in 2024 generated revenue of EUR 3 million (c.£2 million).
Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:
"Bunzl is a highly cash generative business which allows us to prioritise investment in self-funded value-accretive acquisitions to drive growth, and our pipeline remains active. I am pleased to welcome the team from Hospitalia to Bunzl, with the acquisition marking our expansion into the attractive Chilean healthcare market, as well as the team from Inpakomed, who will expand our product and service offering to customers in the Netherlands."
Enquiries:
Bunzl plc Frank van Zanten, Chief Executive Officer Richard Howes, Chief Financial Officer Sunita Entwisle, Head of Investor Relations and Communications Tel: +44 (0)20 7725 5000 |
Teneo Martin Robinson Giles Kernick Tel: +44 (0)20 7353 4200 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.